Sonim Technologies (SONM)
(Delayed Data from NSDQ)
$2.50 USD
0.00 (0.00%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $2.58 +0.08 (3.20%) 7:58 PM ET
5-Strong Sell of 5 5
D Value A Growth C Momentum B VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
SONM 2.50 0.00(0.00%)
Will SONM be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for SONM based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SONM
Analysts Estimate Sonim (SONM) to Report a Decline in Earnings: What to Look Out for
Itron (ITRI) Surpasses Q2 Earnings and Revenue Estimates
SONM: What are Zacks experts saying now?
Zacks Private Portfolio Services
Synaptics (SYNA) Q3 Earnings and Revenues Beat Estimates
InterDigital (IDCC) Beats Q1 Earnings and Revenue Estimates
Sonim (SONM) Stock Drops Despite Market Gains: Important Facts to Note
Other News for SONM
Warning: SONM is at high risk of performing badly
SONM Stock Earnings: Sonim Technologies Misses EPS, Beats Revenue for Q2 2024
Warning: SONM is at high risk of performing badly
Looking Into Sonim Technologies's Recent Short Interest
Why ASLAN Pharmaceuticals Shares Are Trading Lower By Over 38%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session